SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership [amend]
SEC Accession No. 0000950123-11-090834
Filing Date
2011-10-20
Accepted
2011-10-20 09:30:26
Documents
2
Filing Date Changed
2011-10-20
Group Members
QVT ASSOCIATES GP LLCQVT FINANCIAL GP LLCQVT FINANCIAL LPQVT FUND LP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A c23476sc13dza.htm SC 13D/A 70000
2 EXHIBIT 1 c23476exv99w1.htm EX-99.1 10677
  Complete submission text file 0000950123-11-090834.txt   82287
Mailing Address 5871 OBERLIN DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 5871 OBERLIN DRIVE, SUITE 200 SAN DIEGO CA 92121 8585303600
ANADYS PHARMACEUTICALS INC (Subject) CIK: 0001128495 (see all company filings)

IRS No.: 223193172 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-79854 | Film No.: 111149276
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036
Business Address 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036 212-705-8800
QVT Financial LP (Filed by) CIK: 0001290162 (see all company filings)

IRS No.: 113694008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A